A comparison between intratympanic gentamicin and intratympanic steroids for controlling vertigo in Ménière’s disease

Rate this item
(0 votes)


Objective: The purpose of this paper is to review the current literature for intratympanic therapies in the treatment of vertigo in Ménière’s disease. There currently seems to be little consensus about the dosing or the regime in which intratympanic therapies, such as intratympanic gentamicin (ITG) and intratympanic steroids (ITS) including methyl prednisolone and dexamethasone, are delivered. The aim is to review the evidence and suggest effective options.

Methods: A literature search of PubMed and the Cochrane library was conducted and the reference lists were reviewed for additional material. Only papers from 2012 were included in the review to try and give the most up to date picture of current practice.

Results: A total of 30 papers were found and tabulated. 12 papers were included from 2012 onwards.

Conclusion: Both ITG and ITS appear to be effective in controlling vertigo in Ménière’s disease, although ITG appears to be more effective. However, ITG is also associated with more side effects than ITS.

Additional Info

Read 35818 times Last modified on Friday, 05 January 2018 16:09

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.


Member Login

          Forgot login? | Register

BBC News Feed

Get in touch

+44 207 637 3544

This email address is being protected from spambots. You need JavaScript enabled to view it.

The Otorhinolaryngologist,
73 Newman Street, London
W1T 3EJ, 


Rila Publications Ltd Ethics Policy